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Various esters of hydroxymethylpyridine were synthetized and their pharmacological properties 
were investigated. Some of the compounds (1, 8 and 9) displayed better anti-arrhythmic effects than 
that of the quinidine used as reference substance. 
Table I 
Pharmacologycal data of some esters 
We earlier described the synthesis and pharmacological properties of numerous; 
(mainly 1,3-) aminoalkyl esters [1—5]. In some cases considerable local anaesthetic 
[1], coronary vasodilator [4, 5] and bronchial spasmolytic [3] effects were found. 
In the present work the synthesis of various esters of hydroxymethylpyridines is 
reported, together with pharmacolo-
gical data. A number of benzoate 
esters of hydroxymethylpyridine are 
known in the literature [6—9]; a few 
of these possess important pharmaco-
logical (particularly cholinergic and 
hypotensive) effects [10—13]. The new 
derivatives we prepared have been 
examined with regard to their action 
iii inhibiting cardiac arrhythmia in 
anaesthetized cats [14]. This inhibitory 
effect is expressed in an elevation of 
the electric fibrillation threshold of the 
heart. The extent of the effect was 
calculated as the percentage increase 
in the fibrillation threshold compared 
to the level in the untreated control 
animals, and ,in Table I the results are 
compared with those for quinidine, 
Compound 
Elevation of the fibrillation threshold (%) 
2 mg/kg 1 mg/kg 
1 27.6 
2 13.5 




Quinidine 34.5 20.6 











employed successfully as an anti-arrhythmic 
in therapy. In some cases (1, 8 and 9) an im-
proved effect is observed. The esters were 
prepared from the corresponding hydroxy-
methylpyridine on the basis of previous 
descriptions [11]. 2-Hydroxymethylpyridine 
was prepared from 2-picoline [11, 15], and 
3- and 4-hydroxymethylpyridines from the 
ethyl esters of nicotinic and isonicotinic 
acids by a further modification of a known 
method [16]. 
Experimental 
The temperature values given in Tables 
II—V have not been corrected. The purities 
of the compounds were "checked by, among 
others, thin-layer chromatography. Of the 
compounds used, nicotinic acid, isonicotinic 
acid and 2-picolirie were Fluka products. 
The customary method was followed to 
prepare the ethyl esters. 
4-Hydroxymethylpyridine 
A solution of 60 g (0.4 mole) of the ethyl 
ester of isonicotinic acid in 400 ml abs. ether 
was added dropwise. during 1.5 h to a 
solution of 10 g (0.38 mole) Li[AlH4] in 
600 ml abs. ether; 64 ml water was next 
added. The reaction mixture was filtered, 
and the white precipitate was extracted with 
2 x 200 ml ethanol: The organic phases were 
combined, and after a 12-h standing period 
the solution was again filtered. The filtrate 
was evaporated to dryness, and the residue 
was distilled. Yield 25.6 g (59%). 
3-HydroxymethyIpyridine 
This was prepared in a similar way as 
the 4-substituted compound, from the ethyl 
ester of nicotinic acid. Yield 63 %. 
ESTERS O F HYDROXYMETHYLPYRIDINES 1 8 7 
Table IV 
prCHr<T 
No. X M.p. CO Formula 
Analysis 
Cale./Found 
C H N 
7 



















9 • P - Methoiodide 138—139 CI6H13F3INOa 42.58 42.15 3.10 2.92 3.31 3.45 




























13 0 O 0 Methoiodide 150—151 CaiH18INOs 55.04 54.85 3.74 4.08 3.06 3.00 
14 oöo Ethoiodide 141—142 CalHa0INO3 55.95 55.63 4.24 4.46 2.98 3.05 
Table V 
N Q > - C H 2 - O - C - X 
No. X M . p . C O Formula 
Analysis 
Calc./Found 
C H N 




1 8 8 — 1 9 0 C14H14ClNOs 
6 0 . 2 0 
6 0 . 3 5 
5 .04 
5 .08 
5 . 0 0 




1 8 2 — 1 8 3 C I 4 H 1 4 C I N O 3 
6 0 . 2 0 
6 0 . 4 2 
5 .04 
4 . 9 9 
5 . 0 0 
4 . 8 2 
1 8 
H 3 c 0 - O " 
HCl 
1 8 6 — 1 8 8 C 1 4 H 1 4 C I N O S 
60 .20 
60 .08 
5 . 0 4 
4 . 8 5 
5 .05 
5 .15 
1 9 o £ o HCl 1 7 0 — 1 7 2 CMH16C1N03 68 .09 6 7 . 7 5 4 . 2 9 5 . 0 5 3 .97 4 . 1 2 
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2-Picoline-N-oxide i I i 
46.6 g: (0.5 mole) 2-picoline was dissolved in; 300 ml glacial acetic acid, 50 ml 
30% H202 was added, and the solution was kept for 3 hi at '70—80 °C. After the 
addition of a further 35 ml H202 , the reaction mixture was heated for an additional 
9h. The volume was then evaporated to 100 ml,'100 ml'water was added, and the 
solution was evaporated to dryness. The residue was dissolved!in 250 ml chloroform 
and the solution' washed with sodium carbonate solution. After drying, the chloro-
form was evaporated~off, and the residue was distilled. Yield 40 g (74%), with b.p. 
130—135 °G at 20 mm Hg (ljt. [15]: b.p. 123—125 °C at 15 mm Hg), and « f ': 1.5895. 
Acetate ester of 2-hydroxymethylpyridine 
40 g (0.37 mole) 2-picoline-N-oxide: was added dropwise to 75 ml gently boil-
ing acetic anhydride, and the reaction mixture was boiled for 20 min and then dis-
tilled. Yield 42.7 g (77%), with b.p. 128—130 °C at 30 mm Hg (lit. [15]: b.p. 115— 
118 °C at 22 mm Hg), and/if,0: 1.4966: ; 
2-Hydroxymethylpyridine 
A mixture rif 42.7 g;(0.28 mole) of the acetate ester of 2-hydroxymethyIpiyridine 
and 100 ml 27% sodium hydroxide solution was stirred for 12 h at room temperature, 
and then extracted with chloroform (pH=7—8). The chloroform solution was 
dried and evaporated to dryness, and the residue was distilled. Yield 15.2 g (54%). 
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СИНТЕЗ И ФАРМАКОЛОГИЧЕСКОЕ ДЕЙСТВИЕ 
ЭФИРОВ ГИДРОКСИМЕТИЛПИРИДИНОВ 
Ф. Нотейс, К. Фелфелди, М. Барток и Э. Карпаты 
Синтезирован ряд гидроксиметшширидинов и изучено их фармакологическое действие. 
Некоторые из изученных соединений (1, 8,9) обладают лучшим антиаритмическим действием, 
чем хинидин, применявшийся в качестве эталона. V 
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